Further, a study by Henssen et al.254has shown that OTX015, a BRD inhibitor, reduces the viability in MYCN‐amplified NB cells, and shows potency against MYCN‐amplified NB xenografts. The same study has also shown that OTX015 has the potential to disrupt the BRD4‐chromatin interaction and suppress the expression of MYCN in NB cell lines.254. The gene discussed is BRD4; the disease is neuroblastoma.